Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbert J de Winter

Showing results (431-440 of 467) with videos related to

Pageof 47
Sort By:
European Heart Journal. Imaging Methods and Practice|February 26, 2026
Adults with anomalous aortic origin of a coronary artery: impact of invasive functional testing on clinical decision making-insights from the MuSCAT registryDiederick B H Verheijen, Anastasia D Egorova, Frank van der Kley, et al.
Journal of the American College of Cardiology|May 27, 2018
Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CADCarlos Collet, Yosuke Miyazaki, Nicola Ryan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 21, 2019
Quantitative aortography assessment of aortic regurgitationRodrigo Modolo, Chun Chin Chang, Yoshinobu Onuma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 3, 2023
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA studyNiels M R van der Sangen, Bimmer E P M Claessen, I Tarik Küçük, et al.
The Journal of Invasive Cardiology|October 5, 2021
The Impact of Percutaneous Coronary Intervention on Mortality in Patients With Coronary Lesions Who Underwent Transcatheter Aortic Valve ReplacementThomas P W van den Boogert, Jeroen Vendrik, Jetske L B Gunster, et al.
Journal of the American College of Cardiology|October 19, 2019
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCIKuniaki Takahashi, Patrick W Serruys, Ply Chichareon, et al.
International Journal of Cardiology|September 13, 2019
A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trialLaura S M Kerkmeijer, Ruben Y G Tijssen, Sjoerd H Hofma, et al.
Circulation|October 19, 2005
Genetic inflammatory factors predict restenosis after percutaneous coronary interventionsPascalle S Monraats, Nuno M M Pires, Willem R P Agema, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 11, 2019
Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudyRuben Y G Tijssen, Rene J van der Schaaf, Robin P Kraak, et al.
Lancet (London, England)|December 6, 2017
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trialRobbert J de Winter, Yuki Katagiri, Taku Asano, et al.
Pageof 47

Showing results (431-440 of 467) with videos related to

Sort By:
Pageof 47
European Heart Journal. Imaging Methods and Practice|February 26, 2026
Adults with anomalous aortic origin of a coronary artery: impact of invasive functional testing on clinical decision making-insights from the MuSCAT registryDiederick B H Verheijen, Anastasia D Egorova, Frank van der Kley, et al.
Journal of the American College of Cardiology|May 27, 2018
Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CADCarlos Collet, Yosuke Miyazaki, Nicola Ryan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 21, 2019
Quantitative aortography assessment of aortic regurgitationRodrigo Modolo, Chun Chin Chang, Yoshinobu Onuma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 3, 2023
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA studyNiels M R van der Sangen, Bimmer E P M Claessen, I Tarik Küçük, et al.
The Journal of Invasive Cardiology|October 5, 2021
The Impact of Percutaneous Coronary Intervention on Mortality in Patients With Coronary Lesions Who Underwent Transcatheter Aortic Valve ReplacementThomas P W van den Boogert, Jeroen Vendrik, Jetske L B Gunster, et al.
Journal of the American College of Cardiology|October 19, 2019
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCIKuniaki Takahashi, Patrick W Serruys, Ply Chichareon, et al.
International Journal of Cardiology|September 13, 2019
A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trialLaura S M Kerkmeijer, Ruben Y G Tijssen, Sjoerd H Hofma, et al.
Circulation|October 19, 2005
Genetic inflammatory factors predict restenosis after percutaneous coronary interventionsPascalle S Monraats, Nuno M M Pires, Willem R P Agema, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 11, 2019
Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudyRuben Y G Tijssen, Rene J van der Schaaf, Robin P Kraak, et al.
Lancet (London, England)|December 6, 2017
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trialRobbert J de Winter, Yuki Katagiri, Taku Asano, et al.
Pageof 47